NCT02512497 2025-09-19Romidepsin Maintenance After Allogeneic Stem Cell TransplantationOhio State University Comprehensive Cancer CenterPhase 1 Completed23 enrolled
NCT03432741 2025-05-26Direct Tumor Microinjection and FDG-PET in Testing Drug Sensitivity in Patients With Relapsed or Refractory Non-Hodgkin Lymphoma, Hodgkin Lymphoma, or Stage IV Breast CancerMayo ClinicPhase 1 Terminated17 enrolled